ResearcherUniversidad de GranadaActive in the last 2 years
Juan Antonio Marchal
Matched on ORCID iD 0000-0002-4996-8261; OpenAlex author ID A5073290586. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers
Papers 8
- Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. Co-author DOI 10.1038/s41598-025-24863-2↗
- Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells. Co-author DOI 10.3390/ijms26072830↗
- Onychocolone A produced by the fungus Onychocola sp. targets cancer stem cells and stops pancreatic cancer progression by inhibiting MEK2-dependent cell signal… Co-author DOI 10.1016/j.biopha.2024.117018↗
- Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models. Co-author DOI 10.1186/s12885-024-13007-w↗
- Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells. Last author DOI 10.1021/acs.biomac.0c01546↗
- Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting. Co-author DOI 10.1038/s41598-019-47837-7↗
- What's new in treatment of pancreatic cancer: a patent review (2010-2017). Co-author DOI 10.1080/13543776.2017.1349106↗
- What's new in the diagnosis of pancreatic cancer: a patent review (2011-present). Last author DOI 10.1080/13543776.2017.1379991↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Belén Toledo · 3 shared papers, 2024–2025 · strength 0.69
- Paper Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. DOI 10.1038/s41598-025-24863-2↗
- Paper Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells. DOI 10.3390/ijms26072830↗
- Paper Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models. DOI 10.1186/s12885-024-13007-w↗
- Macarena Perán · 3 shared papers, 2019–2025 · strength 0.55
- Paper Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. DOI 10.1038/s41598-025-24863-2↗
- Paper Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models. DOI 10.1186/s12885-024-13007-w↗
- Paper Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engraf… DOI 10.1038/s41598-019-47837-7↗
- Andrea Pisano · 2 shared papers, 2024–2025 · strength 0.42
- Roberto Madeddu · 2 shared papers, 2024–2025 · strength 0.42
- Pablo Hernández-Camarero · 2 shared papers, 2019–2025 · strength 0.37
- María C. Ramos · 3 shared papers, 2017–2024 · strength 0.35
- Paper Onychocolone A produced by the fungus Onychocola sp. targets cancer stem cells and stops pancreatic cancer progression … DOI 10.1016/j.biopha.2024.117018↗
- Paper What's new in treatment of pancreatic cancer: a patent review (2010-2017). DOI 10.1080/13543776.2017.1349106↗
- Paper What's new in the diagnosis of pancreatic cancer: a patent review (2011-present). DOI 10.1080/13543776.2017.1379991↗
- Francisca Vicente · 3 shared papers, 2017–2024 · strength 0.35
- Paper Onychocolone A produced by the fungus Onychocola sp. targets cancer stem cells and stops pancreatic cancer progression … DOI 10.1016/j.biopha.2024.117018↗
- Paper What's new in treatment of pancreatic cancer: a patent review (2010-2017). DOI 10.1080/13543776.2017.1349106↗
- Paper What's new in the diagnosis of pancreatic cancer: a patent review (2011-present). DOI 10.1080/13543776.2017.1379991↗
- Elisa Giovannetti · 1 shared paper, 2025 · strength 0.27
- Grazia Fenu · 1 shared paper, 2025 · strength 0.24
- Alberto Porcu · 1 shared paper, 2024 · strength 0.18
- Grazia Fenu · 1 shared paper, 2024 · strength 0.18
- José Pérez del Palacio · 1 shared paper, 2024 · strength 0.18
- Fernando Reyes · 1 shared paper, 2024 · strength 0.18
- Houría Boulaiz · 2 shared papers, 2017 · strength 0.17
- Saúl A. Navarro-Marchal · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.